Matches in Nanopublications for { ?s ?p "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP180810.RACoIMfcMdUn2K4Nn01HYGqGSCMEkL16jyTKh29hKxwjs130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180810.RACoIMfcMdUn2K4Nn01HYGqGSCMEkL16jyTKh29hKxwjs130_provenance.
- NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_provenance.
- NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_provenance.
- NP350601.RAcBnXspCFH2HvnXLCQ_S0YLgLQ7UNviL10Jt8NGUQP64130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350601.RAcBnXspCFH2HvnXLCQ_S0YLgLQ7UNviL10Jt8NGUQP64130_provenance.
- NP665122.RATDxUlKBfjfUT34CdIhFDe9RWXHxO4hB9W-nVmo1y8zc130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665122.RATDxUlKBfjfUT34CdIhFDe9RWXHxO4hB9W-nVmo1y8zc130_provenance.
- NP758194.RAvjmfG96_OqEjHZ9h7An3AMasSD_FTMfk65mkSfOpZ2A130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758194.RAvjmfG96_OqEjHZ9h7An3AMasSD_FTMfk65mkSfOpZ2A130_provenance.
- NP400705.RAsbraziFnmJcQkf1wnXxIP2Xuq4CEd7kMH9VLkwMdI_w130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400705.RAsbraziFnmJcQkf1wnXxIP2Xuq4CEd7kMH9VLkwMdI_w130_provenance.
- NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400711.RAIlGpeghydjXsgzyxbevTsNuhco4z2mUwGt4bi8QmnCA130_provenance.
- NP400701.RA-JkB0cBk1kjjG7UfaoIJKi_QSmlSaNva-u4AryXiYGE130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400701.RA-JkB0cBk1kjjG7UfaoIJKi_QSmlSaNva-u4AryXiYGE130_provenance.